Quantum Biopharma Ltd. (CVE:QNT) Director Donal Carroll Purchases 500 Shares of Stock
Quantum Biopharma Ltd. (CVE:QNT – Get Free Report) Director Donal Carroll bought 500 shares of Quantum Biopharma stock in a transaction on Monday, July 14th. The stock was purchased at an average price of C$29.22 per share, with a total value of C$14,608.00. Quantum Biopharma Price Performance Analyst Ratings Changes Separately, Singular Research upgraded shares […]
More Stories
Ukraine, Russia and Europe: Why the Future of European Security Is at a Turning Point
European diplomacy faces important questions about security, peace and international cooperation. The war in Ukraine continues to shape Europe's political...
COP31: Can World Leaders Turn Climate Promises into Real Action?
Renewable energy investment is central to the international effort to reduce greenhouse gas emissions. Climate change has become one of...
Who Controls the Machines? The Global Debate Over AI-Powered Autonomous Weapons
Global Affairs and Technology | 16 November 2026 Artificial intelligence is creating new questions about human control, responsibility and the...
How Artificial Intelligence Is Reshaping Global Trade and Creating New Winners
Artificial intelligence is transforming semiconductor manufacturing, international investment and global trade. Image: Unsplash International Business and Technology Artificial intelligence is becoming...
Developing Countries Face a Record Debt Burden as Borrowing Costs Remain High
Infrastructure investment and international financing play a critical role in developing economies. Image: Unsplash International Finance Developing economies are facing a...
The Global Economy Is Resilient, but the Benefits Are Becoming Increasingly Uneven
Global trade and international supply chains remain important drivers of economic activity. Image: Unsplash Economic Analysis The global economy has...
